'Vte risk' diaporamas de présentation

Venous Thromboembolism (VTE) Prevention in the Hospital

Venous Thromboembolism (VTE) Prevention in the Hospital. Greg Maynard MD, MSc Clinical Professor of Medicine and Chief, Division of Hospital Medicine University of California, San Diego. VTE: A Major Source of Mortality and Morbidity. 350,000 to 650,000 with VTE per year

691 views • 48 slides

Introduction to Randomized Clinical Trials

Introduction to Randomized Clinical Trials. Deborah Grady Professor of Medicine University of California, San Francisco. Randomized Trials. Rationale Basic designs Participants Intervention Blinding Outcomes Adherence Follow-up. Rationale. Why do a randomized blinded trial

972 views • 41 slides

Venous Thromboembolism

472 views • 35 slides

Hypercoaguable States What Every Clinician Needs to Know

Hypercoaguable States What Every Clinician Needs to Know. Amjad AlMahameed, MD, MPH Division of Cardiology Beth Israel Deaconess Medical Center. Factor V Leiden (APC Resistance) ? Antithrombin (formerly Antithrombin III) ? Protein C ? Protein S. Prothrombin G20210A mutation

394 views • 31 slides

DVT Prophylaxis of the Medical Patient

DVT Prophylaxis of the Medical Patient. Nicole Artz, MD David Lovinger, MD August, 2006. Case. Mr. Smith- 71 y/o man admitted to general medicine ward service. HPI: gradually increased sob over 3 days assoc. with new productive cough, rhinorrhea, and fatigue.

267 views • 26 slides

VTE Risk Assessment

604 views • 26 slides

391 views • 25 slides

Caprini Score Update 2019

Caprini Score Update 2019. Joseph A. Caprini, MD, MS, FACS, RVT, DVSVS Emeritus, NorthShore University Health System, Evanston, IL Senior Clinician Educator, Pritzker School of Medicine, Chicago, IL. Risk Assessment In Clinical Practice: Guiding Principles. Evidence-Based Guidelines

702 views • 25 slides

Working together to achieve nursing excellence in VTE

Working together to achieve nursing excellence in VTE. Katrina Glaister Clinical Governance Facilitator (VTE Project Nurse) Salisbury NHS Foundation Trust. VTE prophylaxis in Salisbury. Who are we? Where we were Where we are now Top tips!. Salisbury NHS Foundation Trust.

532 views • 22 slides

Venous Thromboembolism

Venous Thromboembolism. Reducing the Risk <Name of session> DATE. Objectives. Define venous thromboembolism Heighten awareness the impact of VTE the preventable nature of VTE Discuss importance of VTE risk assessment appropriate prescribing of prophylaxis engaging patients

1.89k views • 22 slides

Venous Thromboembolism Prevention

Venous Thromboembolism Prevention. August 2010. Expected Practice. Assess all patients upon admission to the ICU for risk factors of venous thromboembolism (VTE) and anticipate orders for VTE prophylaxis based on risk assessment. Expected Practice.

717 views • 18 slides

Primary Thromboprophylaxis in Ambulatory Cancer Patients: Current Guidelines and Updated Evidence

Primary Thromboprophylaxis in Ambulatory Cancer Patients: Current Guidelines and Updated Evidence. Taylor Butler, PharmD, BCOP Decentralized Clinical Pharmacist Department of Veteran Affairs Tennessee Valley Healthcare System. Presentation Objectives.

187 views • 18 slides

Venous Thromboembolism Prophylaxis for Medical Inpatients

Venous Thromboembolism Prophylaxis for Medical Inpatients. Heather Hofmann, rev. 4/18/14 DSR2 Mini Lecture. Objectives. Recognize that VTE carries high morbidity and mortality Determine VTE risk for nonsurgical inpatient Select VTE prophylaxis for the non-surgical inpatient. Background.

384 views • 16 slides

Venous Thromboembolism Prophylaxis for Medical Inpatients

Venous Thromboembolism Prophylaxis for Medical Inpatients. Dennis Whang 4/2/12 DSR2 Mini Lecture. Objectives. Recognize the morbidity and mortality with venous thromboembolism of inpatients Determine the risk of VTE for each nonsurgical inpatient admitted

352 views • 15 slides

Epidemiologic International Day For the Evaluation of Patients at Risk for Venous Thromboembolism in the Acute Hospital

Epidemiologic International Day For the Evaluation of Patients at Risk for Venous Thromboembolism in the Acute Hospital Care Setting. Sponsored by an unrestricted educational grant from sanofi-aventis to the Center for Outcomes Research, University of Massachusetts Medical School.

565 views • 11 slides

Epidemiologic International Day

Epidemiologic International Day For the Evaluation of Patients at Risk for Venous Thromboembolism in the Acute Hospital Care Setting. Sponsored by an unrestricted educational grant from sanofi-aventis to the Center for Outcomes Research, University of Massachusetts Medical School.

238 views • 11 slides